On 24th November 2017, The European Medicines Agency (EMA) released guidance to Marketing Authorisation Holders (MAHs) on Brexit and the UK leaving the EU.
May 2017, the EMA published a notice to Marketing Authorisation Holders (MAHs) that the UK submitted the notification of its intention to withdraw from the EU